Introduced Version
SENATE BILL No. 245
_____
DIGEST OF INTRODUCED BILL
Citations Affected: IC 16-34-6-5; IC 16-42-22.5; IC 35-48-2-10;
IC 35-52-16.
Synopsis: Abortion inducing drugs. Provides that a person who
knowingly or intentionally engages in the use of an abortion inducing
drug, including Mifepristone or Misoprostol, on a pregnant woman
without the knowledge or consent of the pregnant woman, commits a
Level 5 felony. Prohibits a person from knowingly or intentionally
sending Mifepristone or Misoprostol to another person located in
Indiana, if the other person located in Indiana possesses the
Mifepristone or Misoprostol. Provides that each offense is a Class A
misdemeanor with a Level 6 felony for subsequent offenses. Adds
Mifepristone and Misoprostol to the list of Schedule IV drugs.
Effective: July 1, 2025.
Johnson T, Brown L
January 9, 2025, read first time and referred to Committee on Health and Provider
Services.
2025 IN 245—LS 6758/DI 107 Introduced
First Regular Session of the 124th General Assembly (2025)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2024 Regular Session of the General Assembly.
SENATE BILL No. 245
A BILL FOR AN ACT to amend the Indiana Code concerning
health.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 16-34-6-5, AS ADDED BY P.L.93-2022,
2 SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
3 JULY 1, 2025]: Sec. 5. (a) A person who knowingly or intentionally
4 coerces a pregnant woman to have an abortion commits a Level 6
5 felony.
6 (b) A person who knowingly or intentionally engages in the use
7 of an abortion inducing drug, including Mifepristone and
8 Misoprostol, on a pregnant woman without the knowledge or
9 consent of the pregnant woman, commits a Level 5 felony.
10 (c) An offense described in subsection (b) is a Level 4 felony if
11 the unborn child is more than three (3) months of gestational age.
12 SECTION 2. IC 16-42-22.5 IS ADDED TO THE INDIANA CODE
13 AS A NEW CHAPTER TO READ AS FOLLOWS [EFFECTIVE
14 JULY 1, 2025]:
15 Chapter 22.5. Drugs: Mifepristone and Misoprostol Restrictions
16 Sec. 1. This chapter does not apply to:
17 (1) the transport of Mifepristone or Misoprostol from a
2025 IN 245—LS 6758/DI 107 2
1 person in another state in continuous transit through Indiana
2 to a person in another state; or
3 (2) the shipping of Mifepristone or Misoprostol to a hospital
4 or pharmacy.
5 Sec. 2. A person commits unlawful sending of Mifepristone or
6 Misoprostol, a Class A misdemeanor, if:
7 (1) the person knowingly or intentionally sends Mifepristone
8 or Misoprostol to another person located in Indiana; and
9 (2) the other person located in Indiana possesses the
10 Mifepristone or Misoprostol.
11 However, the offense is a Level 6 felony if the person has a prior
12 unrelated conviction for a violation of this section.
13 SECTION 3. IC 35-48-2-10, AS AMENDED BY P.L.84-2024,
14 SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
15 JULY 1, 2025]: Sec. 10. (a) The controlled substances listed in this
16 section are included in schedule IV.
17 (b) Narcotic drugs. Unless specifically excepted in a rule adopted
18 by the board or unless listed in another schedule, any material,
19 compound, mixture, or preparation containing any of the following
20 narcotic drugs, or their salts calculated as the free anhydrous base or
21 alkaloid, in the following limited quantities:
22 (1) Not more than 1 milligram of difenoxin (9618) and not less
23 than 25 micrograms of atropine sulfate per dosage unit.
24 (2) Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-
25 diphenyl-3-methyl-2-propionoxybutane (9278).
26 (c) Depressants. Unless specifically excepted in a rule adopted by
27 the board or unless listed in another schedule, any material, compound,
28 mixture, or preparation which contains any quantity of the following
29 substances, including its salts, isomers, and salts of isomers whenever
30 the existence of such salts, isomers, and salts of isomers is possible
31 within the specific chemical designation:
32 Alfaxalone (2731).
33 Alprazolam (2882).
34 Barbital (2145).
35 Brexanolone (2400).
36 Bromazepam (2748).
37 Camazepam (2749).
38 Carisoprodol.
39 Chloral betaine (2460).
40 Chloral hydrate (2465).
41 Chlordiazepoxide (2744).
42 Clobazam (2751).
2025 IN 245—LS 6758/DI 107 3
1 Clonazepam (2737).
2 Clorazepate (2768).
3 Clotiazepam (2752).
4 Cloxazolam (2753).
5 Daridorexant (2410).
6 Delorazepam (2754).
7 Diazepam (2765).
8 Dichloralphenazone (2467).
9 Estazolam (2756).
10 Ethchlorvynol (2540).
11 Ethinamate (2545).
12 Ethyl loflazepate (2758).
13 Fludiazepam (2759).
14 Flunitrazepam (2763).
15 Flurazepam (2767).
16 Fospropofol (2138).
17 Halazepam (2762).
18 Haloxazolam (2771).
19 Ketazolam (2772).
20 Lemborexant (2245).
21 Loprazolam (2773).
22 Lorazepam (2885).
23 Lormetazepam (2774).
24 Mebutamate (2800).
25 Medazepam (2836).
26 Meprobamate (2820).
27 Methohexital (2264).
28 Methylphenobarbital (mephobarbital) (2250).
29 Midazolam (2884).
30 Nimetazepam (2837).
31 Nitrazepam (2834).
32 Nordiazepam (2838).
33 Oxazepam (2835).
34 Oxazolam (2839).
35 Paraldehyde (2585).
36 Petrichloral (2591).
37 Phenobarbital (2285).
38 Pinazepam (2883).
39 Prazepam (2764).
40 Quazepam (2881).
41 Remimazolam (2846).
42 Suvorexant (2223).
2025 IN 245—LS 6758/DI 107 4
1 Temazepam (2925).
2 Tetrazepam (2886).
3 Triazolam (2887).
4 Zaleplon (2781).
5 Zolpidem (Ambien) (2783).
6 Zopiclone (2784).
7 Zuranolone (2420).
8 (d) Stimulants. Unless specifically excepted in a rule adopted by the
9 board or unless listed in another schedule, any material, compound,
10 mixture, or preparation which contains any quantity of the following
11 substances having a stimulant effect on the central nervous system,
12 including its salts, isomers (whether optical, position, or geometric),
13 and salts of such isomers whenever the existence of such salts, isomers,
14 and salts of isomers is possible within the specific chemical
15 designation:
16 Cathine ((+)-norpseudoephedrine) (1230).
17 Diethylpropion (1610).
18 Fencamfamin (1760).
19 Fenproporex (1575).
20 Mazindol (1605).
21 Mefenorex (1580).
22 Modafinil (1680).
23 Pemoline (including organometallic complexes and chelates
24 thereof) (1530).
25 Phentermine (1640).
26 Pipradrol (1750).
27 Serdexmethylphenidate (1729).
28 Sibutramine (1675).
29 Solriamfetol (2-amino-3-phenylpropyl carbamate;
30 benzenepropanol, beta-amino-, carbamate (ester)) (1650).
31 SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
32 (e) Other substances. Unless specifically excepted or unless listed
33 in another schedule, any material, compound, mixture, or preparation
34 which contains any quantity of the following substances including its
35 salts:
36 Butorphanol (including its optical isomers) (9720).
37 Pentazocine (9709).
38 (f) Tramadol (Ultram).
39 (g) Mifepristone.
40 (h) Misoprostol.
41 (g) (i) The board may except by rule any compound, mixture, or
42 preparation containing any depressant substance listed in subsection
2025 IN 245—LS 6758/DI 107 5
1 (b), (c), (d), or (e), from the application of any part of this article if the
2 compound, mixture, or preparation contains one (1) or more active
3 medicinal ingredients not having a depressant effect on the central
4 nervous system, and if the admixtures are included therein in
5 combinations, quantity, proportion, or concentration that vitiate the
6 potential for abuse of the substances which have a depressant effect on
7 the central nervous system.
8 SECTION 4. IC 35-52-16-23.5, AS ADDED BY P.L.93-2022,
9 SECTION 6, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
10 JULY 1, 2025]: Sec. 23.5. IC 16-34-6-5 defines a crime crimes
11 concerning coerced abortion and the use of abortion inducing drugs
12 without the knowledge or consent of the pregnant woman.
13 SECTION 5. IC 35-52-16-90.1 IS ADDED TO THE INDIANA
14 CODE AS A NEW SECTION TO READ AS FOLLOWS
15 [EFFECTIVE JULY 1, 2025]: Sec. 90.1. IC 16-42-22.5-2 defines a
16 crime concerning abortion inducing drugs.
2025 IN 245—LS 6758/DI 107